Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sara Quenet"'
Autor:
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E. Cortes, Timothy P. Hughes, Jane F. Apperley, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, Valentin García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J. Mauro
Publikováno v:
Leukemia. 37:617-626
Asciminib, the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP), is approved worldwide for the treatment of adults with Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase (CML-CP) treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::925b1dff371f56d5e87a1cf9f4fe14f0
https://doi.org/10.1038/s41375-023-01829-9
https://doi.org/10.1038/s41375-023-01829-9
Autor:
Philipp le Coutre, Véronique Bédoucha, Delphine Rea, Dennis Dong Hwan Kim, Elza Lomaia, Michael J. Mauro, Andre Abdo, Lynette Chee, Sergey Voloshin, Dong-Wook Kim, Laura Fogliatto, Paola Aimone, Yosuke Minami, Alex Allepuz, Mario Annunziata, Jane F. Apperley, Susanne Saussele, Jorge E. Cortes, Andreas Hochhaus, Naeem Chaudhri, Carla Boquimpani, Koji Sasaki, Sara Quenet, Timothy P. Hughes, Anna G. Turkina, Valentín García-Gutiérrez
Publikováno v:
Blood
Patients with chronic myeloid leukemia in chronic phase (CML-CP) resistant/intolerant to ≥2 tyrosine kinase inhibitors (TKIs) are at high risk of experiencing poor outcomes because of disease biology and inadequate efficacy and/or safety of current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ea953c680d4e6fe9a23516537c5aa9
https://doi.org/10.1182/blood.2020009984
https://doi.org/10.1182/blood.2020009984
Autor:
Delphine Réa, Andreas Hochhaus, Michael J. Mauro, Yosuke Minami, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong-Wook Kim, Jane F. Apperley, Jorge E. Cortes, Andre Abdo, Laura Marie Fogliatto, Dennis Dong Hwan Kim, Philipp le Coutre, Susanne Saussele, Mario Annunziata, Timothy P. Hughes, Naeem Chaudhri, Lynette Chee, Valentin García-Gutiérrez, Koji Sasaki, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Carla Boquimpani
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S295-S296
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b07a2974b263a917ddb74f309da3f09f
https://doi.org/10.1016/s2152-2650(22)01379-9
https://doi.org/10.1016/s2152-2650(22)01379-9
Autor:
Delphine Réa, Andreas Hochhaus, Michael J. Mauro, Yosuke Minami, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong-Wook Kim, Jane F. Apperley, Jorge E. Cortes, Andre Abdo, Laura Marie Fogliatto, Dennis Dong Hwan Kim, Philipp le Coutre, Susanne Saussele, Mario Annunziata, Timothy P. Hughes, Naeem Chaudhri, Lynette Chee, Valentin García-Gutiérrez, Koji Sasaki, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Carla Boquimpani
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fb133b2aeaf6d7ce8df88e584eed0da
https://doi.org/10.1016/s2152-2650(22)00881-3
https://doi.org/10.1016/s2152-2650(22)00881-3
Autor:
Delphine Rea, Michael J. Mauro, Andreas Hochhaus, Carla Boquimpani, Elza Lomaia, Sergey Voloshin, Anna G. Turkina, Dong-Wook Kim, Jane Apperley, Jorge E. Cortes, Koji Sasaki, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Yosuke Minami
Publikováno v:
Journal of Clinical Oncology. 40:7004-7004
7004 Background: Asciminib is the first BCR::ABL1 inhibitor to specifically target the ABL Myristoyl Pocket (STAMP). In the ASCEMBL primary analysis, asciminib had superior efficacy and better safety/tolerability than BOS in pts with CML-CP after ≥
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::116a3e7cd2c088524bc83c36e0a83c8a
https://doi.org/10.1200/jco.2022.40.16_suppl.7004
https://doi.org/10.1200/jco.2022.40.16_suppl.7004
Autor:
Carmelo Rizzari, Hiroyuki Shimada, Frédéric Millot, Christian M. Zwaan, Terri Guinipero, Keon Hee Yoo, Francisco Bautista, Darintr Sosothikul, Carlo Dufour, Paola Aimone, Alex Allepuz, Alexey Maschan, Sabine Hertle, Zeynep Karakas, Hyoung Jin Kang, Sara Quenet, S. Ducassou, Hiroaki Goto, Nobuko Hijiya, Florence Hourcade-Potelleret
Publikováno v:
Blood, 134:WOS:000506623900007, 2036-2045. American Society of Hematology
Chronic myeloid leukemia (CML) is rare in children and accounts for £15% of all myeloid leukemia cases. When we initiated this study with nilotinib, imatinib was the only tyrosine kinase inhibitor indicated for pediatric patients with Philadelphia c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fcac1278f778f3e24d19e0d6e9b1a13
https://pure.eur.nl/en/publications/3544bed1-5d53-4046-a784-91a124f70cfc
https://pure.eur.nl/en/publications/3544bed1-5d53-4046-a784-91a124f70cfc
Autor:
Claire Boutet, Fabrice-Guy Barral, Jérôme Varvat, Laure Rouffiange-Leclair, Pierre Garnier, Magali Epinat, Daphné Delsart, Patrick Mismetti, Fabien Schneider, Jean-Christophe Antoine, Sara Quenet
Publikováno v:
European Journal of Radiology. 83:824-828
To compare magnetic resonance imaging (MRI) brain feature in cryptogenic stroke patients with patent foramen ovale (PFO), cryptogenic stroke patients without PFO and patients with cardioembolic stroke.The ethics committee required neither institution
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f65e5ca7f09b9c5eec4bb39e35a484
https://doi.org/10.1016/j.ejrad.2014.01.022
https://doi.org/10.1016/j.ejrad.2014.01.022
Autor:
Sara Quenet, Xavier Delavenne, Claire Flaujac, Virginie Siguret, Thomas Lecompte, Marie-Hélène Horellou, Isabelle Gouin-Thibault, Silvy Laporte
Publikováno v:
Thrombosis and Haemostasis. 112:240-248
SummaryWhile laboratory monitoring is not required in patients treated with apixaban, a direct factor-Xa inhibitor, assessment of its concentration is useful in some critical situations. However, few data are available on its effect on coagulation te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b06a6780ecd392b9d56c4e9d48c26417
https://doi.org/10.1160/th13-06-0470
https://doi.org/10.1160/th13-06-0470
Autor:
Jan Geissler, Stephan Hois, Sara Quenet, Florence Hourcade-Potelleret, Sabine Hertle, G. Saglio, Jorge E. Cortes, Timothy P. Hughes
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S222-S223
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10fee19b3c13305892e32e253a41ed2e
https://doi.org/10.1016/j.clml.2018.07.093
https://doi.org/10.1016/j.clml.2018.07.093
Autor:
Céline Chauleur, Silvy Laporte, Hervé Decousus, Sara Quenet, Pierre Seffert, M.-N. Varlet, Patrick Mismetti
Publikováno v:
Thrombosis Research. 122:478-484
Introduction Management of pregnant women at increased risk of venous thromboembolism (VTE) remains complex in the absence of an easy-to-use tool allowing individualised, risk-adapted prophylaxis. Our objective was to assess whether treatment based o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6bcdcf7a305c97420e10a21b1e67482
https://doi.org/10.1016/j.thromres.2007.12.020
https://doi.org/10.1016/j.thromres.2007.12.020